GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Centene Corp (NYSE:CNC) » Definitions » Beneish M-Score

Centene (Centene) Beneish M-Score : -2.75 (As of Apr. 26, 2024)


View and export this data going back to 2001. Start your Free Trial

What is Centene Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.75 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Centene's Beneish M-Score or its related term are showing as below:

CNC' s Beneish M-Score Range Over the Past 10 Years
Min: -2.75   Med: -2.32   Max: -1.75
Current: -2.75

During the past 13 years, the highest Beneish M-Score of Centene was -1.75. The lowest was -2.75. And the median was -2.32.


Centene Beneish M-Score Historical Data

The historical data trend for Centene's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Centene Beneish M-Score Chart

Centene Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.28 -2.20 -2.19 -2.72 -2.75

Centene Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.72 -3.01 -2.92 -2.71 -2.75

Competitive Comparison of Centene's Beneish M-Score

For the Healthcare Plans subindustry, Centene's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Centene's Beneish M-Score Distribution in the Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, Centene's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Centene's Beneish M-Score falls into.



Centene Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Centene for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0985+0.528 * 1.0248+0.404 * 0.902+0.892 * 1.0654+0.115 * 0.6392
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.0175+4.679 * -0.073428-0.327 * 1.014
=-2.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was $15,532 Mil.
Revenue was 39460 + 38042 + 37608 + 38889 = $153,999 Mil.
Gross Profit was 3660 + 4551 + 4530 + 4574 = $17,315 Mil.
Total Current Assets was $40,756 Mil.
Total Assets was $84,641 Mil.
Property, Plant and Equipment(Net PPE) was $2,415 Mil.
Depreciation, Depletion and Amortization(DDA) was $1,293 Mil.
Selling, General, & Admin. Expense(SGA) was $12,563 Mil.
Total Current Liabilities was $36,716 Mil.
Long-Term Debt & Capital Lease Obligation was $18,590 Mil.
Net Income was 45 + 469 + 1058 + 1130 = $2,702 Mil.
Non Operating Income was 350 + -226 + 407 + 333 = $864 Mil.
Cash Flow from Operations was 217 + 1021 + 2546 + 4269 = $8,053 Mil.
Total Receivables was $13,272 Mil.
Revenue was 35561 + 35865 + 35936 + 37185 = $144,547 Mil.
Gross Profit was 3847 + 3972 + 4484 + 4353 = $16,656 Mil.
Total Current Assets was $30,128 Mil.
Total Assets was $76,870 Mil.
Property, Plant and Equipment(Net PPE) was $4,986 Mil.
Depreciation, Depletion and Amortization(DDA) was $1,430 Mil.
Selling, General, & Admin. Expense(SGA) was $11,589 Mil.
Total Current Liabilities was $28,464 Mil.
Long-Term Debt & Capital Lease Obligation was $21,071 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(15532 / 153999) / (13272 / 144547)
=0.100858 / 0.091818
=1.0985

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(16656 / 144547) / (17315 / 153999)
=0.115229 / 0.112436
=1.0248

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (40756 + 2415) / 84641) / (1 - (30128 + 4986) / 76870)
=0.489952 / 0.543203
=0.902

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=153999 / 144547
=1.0654

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(1430 / (1430 + 4986)) / (1293 / (1293 + 2415))
=0.22288 / 0.348706
=0.6392

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(12563 / 153999) / (11589 / 144547)
=0.081578 / 0.080175
=1.0175

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((18590 + 36716) / 84641) / ((21071 + 28464) / 76870)
=0.653419 / 0.6444
=1.014

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(2702 - 864 - 8053) / 84641
=-0.073428

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Centene has a M-score of -2.75 suggests that the company is unlikely to be a manipulator.


Centene Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Centene's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Centene (Centene) Business Description

Address
7700 Forsyth Boulevard, Centene Plaza, St. Louis, MO, USA, 63105
Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 24 million medical members as of June 2023, mostly in Medicaid (67% of membership), the individual exchanges (14%), and Medicare Advantage (6%) plans. The company also serves traditional Medicare users with its Medicare Part D pharmaceutical program.
Executives
Lori Jean Robinson director 5875 LANDERBROOK DRIVE, SUITE 220, CLEVELAND OH 44124
Andrew Lynn Asher officer: EVP, CFO 8735 HENDERSON ROAD, TAMPA FL 33634
James E Murray officer: EVP, Chief Transform. Officer 500 WEST MAIN STREET, LOUISVILLE KY 40202
Samuels Theodore R. Ii director 1990 E. GRAND AVE., EL SEGUNDO CA 90245
Monte E Ford director C/O AKAMAI TECHNOLOGIES, INC., 8 CAMBRIDGE CENTER, CAMBRIDGE MA 02142
Kenneth J Fasola officer: EVP, Health Care Enterprises 500 WEST MAIN STREET, LOUISVILLE KY 40202
Shannon Bagley officer: EVP, Chief Admin. Officer 7700 FORSYTH BOULEVARD, CLAYTON MO 63105
Richard A Gephardt director 822 CAPITOL SQUARE PLACE, SW, WASHINGTON DC 20024
Christopher J Coughlin director
H James Dallas director 127 PUBLIC SQUARE, CLEVELAND OH 44114
Mark J Brooks officer: SVP, Chief Information Officer 7700 FORSYTH BOULEVARD, ST. LOUIS MO 63105
David P Thomas officer: EVP, MARKETS 7700 FORSYTH BOULEVARD, ST. LOUIS MO 63105
Leslie V Norwalk director C/O 3661 VALLEY CENTRE DRIVE SUITE 200, SAN DIEGO CA 92130
Wayne S Deveydt director 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204
Toney Colin A officer: EVP, Mergers & Acquisitions 7700 FORSYTH BOULEVARD, ST. LOUIS MO 63105

Centene (Centene) Headlines

From GuruFocus

Q4 2021 Centene Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q3 2022 Centene Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024

Centene Corp Investor Day Transcript

By GuruFocus Research 01-22-2024

Centene Corp Investor Day Transcript

By GuruFocus Research 01-22-2024